Gan & Lee Pharmaceuticals Co (SHSE:603087) Growth Rank : 6 (As of Apr. 17, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Gan & Lee Pharmaceuticals Co Growth Rank?

Gan & Lee Pharmaceuticals Co has the Growth Rank of 6.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Gan & Lee Pharmaceuticals Co's Growth Rank

For the Medical Instruments & Supplies subindustry, Gan & Lee Pharmaceuticals Co's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gan & Lee Pharmaceuticals Co's Growth Rank Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gan & Lee Pharmaceuticals Co's Growth Rank distribution charts can be found below:

* The bar in red indicates where Gan & Lee Pharmaceuticals Co's Growth Rank falls into.

Save Embed

;

Save Embed

;

Gan & Lee Pharmaceuticals Co Growth Rank Related Terms

Thank you for viewing the detailed overview of Gan & Lee Pharmaceuticals Co's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Gan & Lee Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gan & Lee Pharmaceuticals Co Ltd (SHSE:603087) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, 1st Nanfeng West Road, Zhenxian Town, Tongzhou District, Beijing, CHN, 101102

Website

http://www.ganlee.com

Gan & Lee Pharmaceuticals Co Ltd is a biopharmaceutical company specialized in research, development, production and commercialization of insulin and its analogues in the diabetes market in China. The company is engaged in production and sales of recombinant insulin analog raw materials and injections. It has launched multiple biosimilar insulin analogue products, including the super long-acting insulin glargine Basalin, the super quick-acting insulin lispro Prandilin, and the pre-mixed insulin analogue Prandilin 25.

Executives

Gan Zhong Ru

Director

Gan & Lee Pharmaceuticals Co Headlines

No Headlines